CS
BNTX icon

Credit Suisse’s BioNTech BNTX Stock Holding History

Credit Suisse’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$3.72M Sell
40,292
-31,681
-44% -$3.04M ﹤0.01% 1466
2023
Q4 		$7.6M Sell
71,973
-2,231
-3% -$225K 0.01% 1086
2023
Q3 		$8.06M Sell
74,204
-9,612
-11% -$1.06M 0.01% 996
2023
Q2 		$9.05M Buy
83,816
+15,570
+23% +$1.75M 0.01% 972
2023
Q1 		$8.5M Buy
68,246
+36,579
+116% +$5.02M 0.01% 1004
2022
Q4 		$4.76M Sell
31,667
-32,479
-51% -$5M 0.01% 1336
2022
Q3 		$8.65M Sell
64,146
-17,486
-21% -$2.67M 0.01% 986
2022
Q2 		$12.2M Sell
81,632
-20,373
-20% -$3.11M 0.01% 867
2022
Q1 		$17.4M Buy
102,005
+51,803
+103% +$8.7M 0.01% 823
2021
Q4 		$12.9M Sell
50,202
-82,305
-62% -$22.5M 0.01% 1315
2021
Q3 		$36.2M Buy
132,507
+79,436
+150% +$25.2M 0.02% 785
2021
Q2 		$11.9M Buy
53,071
+14,658
+38% +$2.76M 0.01% 1444
2021
Q1 		$4.19M Sell
38,413
-172,150
-82% -$18.3M ﹤0.01% 2222
2020
Q4 		$17.2M Buy
210,563
+184,896
+720% +$18.2M 0.01% 1257
2020
Q3 		$1.78M Buy
25,667
+10,312
+67% +$740K ﹤0.01% 2500
2020
Q2 		$1.02M Sell
15,355
-5,349
-26% -$267K ﹤0.01% 2890
2020
Q1 		$1.21M Sell
20,704
-4,446
-18% -$173K ﹤0.01% 2501
2019
Q4 		$852K Buy
+25,150
New +$564K ﹤0.01% 3241

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Credit Suisse's BNTX Position: Q1 2024 in Review

Credit Suisse reduced its BioNTech (BNTX) stake by 44% in Q1 2024, selling an estimated $3.04M and leaving 40,292 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

Credit Suisse first reported a position in BNTX in Q4 2019 and has held it in 18 quarters since. The position peaked at $36.2M in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2024.

  • Credit Suisse held 40,292 shares of BioNTech worth $3.72M as of Q1 2024.
  • Credit Suisse sold 31,681 BioNTech shares in Q1 2024, an estimated $3.04M.
  • BioNTech made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1466 holding.
  • Credit Suisse first reported a position in BioNTech in Q4 2019 and has held it in 18 quarters since.
  • Credit Suisse's BioNTech position peaked at $36.2M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.